HMSC- A simple breast cancer screening device Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : HMSC- A simple breast cancer screening device

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Mike K. who wrote ()	3/17/1998 3:27:00 PM
From: MaximilianII	Read Replies (1) of 246

I have been long a substantial number of shares for quite some time since, IMO, HMSC offers superior appreciation potential (just 2 weeks ago, HMSC traded as high as 13 3/8). HMSC has traded in a fairly predictable pattern over the past six months ranging between $7.5 - $12.5. IMO, HMSC will break out of this range in the very near future. As management hits the road and visits institutional investors this week, the stock should regain momentum. I heard of one firm, which purchased over 100,000 shares 2 weeks ago. There is bound to be some additional buying in the coming days. The publicity generated from Jill Eikenberry's appearances has brought the BreastAlert to the attention of millions of potential users. Just last week, a local news station in N.Y.C. did a brief story on the product. My due diligence has convinced me to stay with this one, despite having had numerous opportunities to cash out at an 80+% profit. The short sellers posting here should not deter those of you who are considering increasing your stake or getting in for the first time. I am aware of one Wall Street analyst and one health care executive who believe BreastAlert has the potential to become the product of the decade. There are many women who visit primary care physicians in the U.S. Primary care docs are not as skilled in performing a breast exam as an OBGYN. These docs are deriving additional confidence in performing the breast exam through having additional data from this adjunctive screening device. Plain and simple! OBGYN's can be expected to as a group once the results from large scale clinicals are published. It's only a matter of time. At that point, the stock will have run up 2-4x from current levels IMO.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next